![PDF) Association of compliance of ventilator bundle with incidence of ventilator-associated pneumonia and ventilator utilization among critical patients over 4 years PDF) Association of compliance of ventilator bundle with incidence of ventilator-associated pneumonia and ventilator utilization among critical patients over 4 years](https://www.researchgate.net/publication/266574147/figure/fig1/AS:411254654029825@1475062158212/Comparisons-of-ventilator-bundle-compliance-VAP-rate-and-ventilator-utilization-between_Q320.jpg)
PDF) Association of compliance of ventilator bundle with incidence of ventilator-associated pneumonia and ventilator utilization among critical patients over 4 years
![PDF) Association of compliance of ventilator bundle with incidence of ventilator-associated pneumonia and ventilator utilization among critical patients over 4 years PDF) Association of compliance of ventilator bundle with incidence of ventilator-associated pneumonia and ventilator utilization among critical patients over 4 years](https://i1.rgstatic.net/publication/266574147_Association_of_compliance_of_ventilator_bundle_with_incidence_of_ventilator-associated_pneumonia_and_ventilator_utilization_among_critical_patients_over_4_years/links/57eba98b08ae4119b2833db3/largepreview.png)
PDF) Association of compliance of ventilator bundle with incidence of ventilator-associated pneumonia and ventilator utilization among critical patients over 4 years
![Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial - The Lancet Infectious Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial - The Lancet Infectious](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/f85f5018-3b8f-436f-b05e-3b7c10fcd584/gr1.jpg)
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial - The Lancet Infectious
![PDF) Synergistic Activity Comparison between Colistin/Tigecycline and Colistin/High Dose Meropenem against Carbapenem Resistant Enetrobacteriaceae in Critically Ill Patients with Ventilator Associated Pneumoniae | IRJPMS Editor - Academia.edu PDF) Synergistic Activity Comparison between Colistin/Tigecycline and Colistin/High Dose Meropenem against Carbapenem Resistant Enetrobacteriaceae in Critically Ill Patients with Ventilator Associated Pneumoniae | IRJPMS Editor - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/63935393/mini_magick20200716-26188-qx7lmb.png?1594885580)